Peptide receptor radionuclide therapy (PRRT) is an established treatment for grade 1 and 2
gastroenteropancreatic neuroendocrine tumors with an increased uptake on somatostatin …

Neuroendocrine tumors are a heterogeneous group of neoplasms that are best worked up
and managed using a variety of clinical and imaging studies. They are often diagnosed after …

Previous ENETS guidelines [1, 8, 9] have discussed extensively the clinical symptomology,
diagnosis and treatment of localized, regionalized as well as distant Si-NENs. This fourth …

Since highly proliferative carcinomas with a neuroendocrine phenotype but poor histological
differentiation grade are extremely rare in the jejuno-ileum, management of such cases …

Functional techniques are playing a pivotal role in the imaging of cancer today. Our aim was
to compare, on a head-to-head basis, 3 functional imaging techniques in patients with …

The treatment of metastatic neuroendocrine tumors depends on the aggressiveness of the
disease. We wanted to know whether 18F-FDG PET and somatostatin receptor scintigraphy …

Despite the fact that several studies have been published regarding the prognostic factors of
neuroendocrine tumors (NETs), there are some cases in which available data are not …

Introduction: Recently, there have been a number of advances in imaging pancreatic
neuroendocrine tumors (panNETs), as well as other neuroendocrine tumors (NETs), which …

Somatostatin-producing neuroendocrine tumors (SOM-NETs) of the duodenum and
pancreas appear to be heterogeneous. To determine their clinicopathological profiles …

The diagnosis of neuroendocrine tumours (NETs) and monitoring of therapy in many
patients relies mainly on morphological imaging techniques such as computed tomography …